Literature DB >> 10771933

Toxoplasmosis in women of child bearing age and infant follow up after in-utero treatment.

P Chakraborty1, S Sinha, S Adhya, G Chakraborty, P Bhattacharya.   

Abstract

A total of 540 women (including 70 pregnant cases) of child bearing age with bad obstetrical history were tested serologically for anti-toxoplasma antibody using microlatex agglutination test. Forty two women including 5 cases of pregnancy were found to be seropositive in a titre of 1:32 or more. Maximum prevalence (10.2%) and highest titer of anti-toxoplasma antibodies were observed in women of 35-42 years age group. The overall prevalence of toxoplasmosis in these women was 7.7%, whereas it was 7.1% in pregnant women. Further studies are needed to estimate the exact rate of prevalence of infection. Of the 70 pregnant women, 5 were seropositive and two of them acquired infection during pregnancy which was detected by IgM immunosorbent assay. Seropositive pregnant women were treated using combined regimen of sulfadiazine and pyrimethamine. Four infected women with pregnancy were followed up and one did not turn up subsequently. There was spontaneous abortion in one case and in 3 other cases full term normal babies were delivered. Incidence of toxoplasmosis in women is low because of infrequent and uncommon practices of ingesting undercooked or uncooked food stuff specially meat by a substantial number of the population surveyed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10771933     DOI: 10.1007/bf02725516

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  The diagnosis of toxoplasmosis.

Authors:  S E Anderson; J S Remington
Journal:  South Med J       Date:  1975-11       Impact factor: 0.954

2.  Serological study of patients clinically suspected to have toxoplasmosis in Kashmir.

Authors:  M A Thokar; N Malla; C Wattal
Journal:  Indian J Med Res       Date:  1988-07       Impact factor: 2.375

3.  Toxoplasmosis: the time has come.

Authors:  R McCabe; J S Remington
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

4.  Serological survey of toxoplasma antibodies in Chandigarh area (Northern India).

Authors:  R C Mahajan; N L Chitkara; J G Jolly
Journal:  Indian J Med Res       Date:  1974-01       Impact factor: 2.375

5.  Toxoplasmosis in South India--a serological study.

Authors:  V N Bhatia; K Meenakshi; S C Agarwal
Journal:  Indian J Med Res       Date:  1974-12       Impact factor: 2.375

6.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

7.  In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.

Authors:  J Couvreur; P Thulliez; F Daffos; C Aufrant; Y Bompard; A Gesquière; G Desmonts
Journal:  Fetal Diagn Ther       Date:  1993 Jan-Feb       Impact factor: 2.587

8.  What can be done to prevent congenital toxoplasmosis?

Authors:  C B Wilson; J S Remington
Journal:  Am J Obstet Gynecol       Date:  1980-10-15       Impact factor: 8.661

  8 in total
  3 in total

Review 1.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

2.  Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

3.  Seroprevalence of toxoplasmosis in antenatal women with bad obstetric history.

Authors:  Suryamani Chintapalli; I Jyothi Padmaja
Journal:  Trop Parasitol       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.